New Leaf News

Portfolio Companies

Business Wire logo

Save

New Leaf Ventures Names Martin Mackay, Ph.D., as Senior Advisor
June 4, 2018

New Leaf Venture Partners Sprouts $200M Growth Fund
June 22, 2015

Biotechnology Boom is Here to Stay, Investors Say
October 14, 2013

New Leaf Venture Partners Affirms Its Support of Roumell Asset Management’s Letter to Transcept Pharmaceuticals’ Board
September 9, 2013

New Leaf Venture Partners’ Liam Ratcliffe, M.D., Ph.D., Elected to Array BioPharma’s Board of Directors
April 30, 2012

New Leaf Venture Partners Invests in New Health IT Initiative to Make NYS a Hub for High-Tech Jobs
April 26, 2012

New Leaf Venture Partners Names Reza Zadno, Ph.D., as Venture Partner
January 7, 2011

Venture Firms Feel The Pain With GlaxoSmithKline Spin-Off
October 4, 2010

New Leaf Venture Partners Appoints Dr. Srinivas Akkaraju as Managing Director and Lead of the Firm’s West Coast Biopharmaceuticals Practice
January 16, 2009

New Leaf Venture Partners Expands Leadership Team, Naming Liam Ratcliffe, M.D., Ph.D., as Venture Partner
September 2, 2008

New Leaf Venture Partners Closes $450 Million Healthcare Fund
October 10, 2007

New Leaf Venture Partners Names Milton B. McColl, M.D. as Venture Partner
April 16, 2007

New Leaf Venture Partners Closes $310 Million Healthcare Fund; Focus on Clinical-Stage Biopharmaceutical Products, Early-Stage Medical Devices, and Molecular Diagnostics
August 09, 2005